Physician profile
Ann E Reese
NPI 1295037919
$1,231.28
in general payments reported to CMS, 2019-2025
10 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.20 · 2022: $172 · 2023: $305 · 2024: $509 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $352.10 | 2024 | |
| Abbvie INC. | $233.92 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $133.56 | 2023 | Rexulti |
| Phathom Pharmaceuticals, INC. | $125.00 | 2025 | Voquezna |
| Amgen INC. | $121.80 | 2023 | Repatha |
| Novo Nordisk INC | $97.55 | 2022 | |
| Sanofi-Aventis U.S. LLC | $74.80 | 2022 | |
| Insmed, INC. | $49.96 | 2023 | Arikayce |
| Neurocrine Biosciences, INC. | $23.33 | 2025 | |
| Boston Scientific Corporation | $19.26 | 2024 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Reese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.